BME Research | Milton Maxwell

BME

BlackRock Health Sciences Trust

40.60

-0.47-1.14%

Dec 16, 4:00:02 PM EST

Upcoming Earnings

Report date

≈ -/-

Earnings Call Transcripts

This Quarter (Q4 '25)

No earnings call transcript available yet

Last Quarter (Q3 '25)

No earnings call transcript available

Key Stats

Market Cap

524.72M

P/E (TTM)

Basic EPS (TTM)

-1.99

Dividend Yield

0.07%

Recent Filings

8-K

Standstill deal with Saba

1/21/25Jan 21, 2025

BlackRock Health Sciences Trust inked a standstill pact with Saba Capital Management on January 20, 2025, curbing activist moves until after the 2027 shareholder meeting or August 31, 2027. Saba pledges to back the board's voting slate and skip proxy fights or board challenges. This truce shields governance stability. Litigation looms if breached.

8-K

Bylaws amended for trustee elections

10/28/16Oct 28, 2016

BlackRock Health Sciences Trust amended its bylaws on October 28, 2016, restating them entirely to revise trustee election procedures in Article I, Section 11. Effective immediately, this update streamlines governance without altering other core operations. The full text appears in Exhibit 3.1. No financial impacts disclosed.

8-K

Annual meeting scheduled

2/4/11Feb 4, 2011

BlackRock Health Sciences Trust announced its 2011 Annual Meeting of Shareholders for July 28, 2011, setting deadlines for proposals under Rule 14a-8 by February 28 and other nominations by February 14. This routine governance step ensures shareholder input amid market volatility. Deadlines lock in now.

8-K

Bylaws fully restated

10/29/10Oct 29, 2010

BlackRock Health Sciences Trust amended and restated its bylaws in full on October 25, 2010, effective October 28. This update, filed under Regulation FD, streamlines governance without altering core operations. The board approved the changes to align with current standards. No financial impacts disclosed.

8-K

Bylaws amended for standardization

10/7/08Oct 7, 2008

BlackRock Health Sciences Trust amended and restated its bylaws effective May 29, 2008, to standardize governance across BlackRock's closed-end funds, enable Direct Registration System eligibility for its shares, and introduce advance notice rules for shareholder proposals on director nominations or other business at meetings after the 2008 annual gathering. This filing, reported October 7, 2008, under Regulation FD, promotes uniformity while curbing surprise proposals. No financial impacts disclosed. Bylaws align operations seamlessly.

About

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

CEO

Mr. Charles Choon Sik Park

IPO

3/29/2005

Website

https://www.blackrock.com/investing/products/240227/blackrock-health-sciences-trust-usd-fund

Sector

Financial Services

Industry

Asset Management